TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 95 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $69,000 | +13.1% | 51,274 | -4.7% | 0.00% | – |
Q4 2018 | $61,000 | -51.6% | 53,787 | +17.7% | 0.00% | – |
Q3 2018 | $126,000 | -22.2% | 45,687 | +0.9% | 0.00% | – |
Q2 2018 | $162,000 | -50.0% | 45,282 | -11.9% | 0.00% | – |
Q4 2017 | $324,000 | -8.2% | 51,382 | -0.5% | 0.00% | – |
Q3 2017 | $353,000 | +3.8% | 51,639 | +8.4% | 0.00% | – |
Q2 2017 | $340,000 | -57.8% | 47,633 | -45.7% | 0.00% | – |
Q1 2017 | $806,000 | +475.7% | 87,682 | +152.8% | 0.00% | – |
Q4 2016 | $140,000 | +17.6% | 34,690 | +11.7% | 0.00% | – |
Q3 2016 | $119,000 | -10.5% | 31,067 | +0.7% | 0.00% | – |
Q2 2016 | $133,000 | -93.8% | 30,843 | -31.3% | 0.00% | -100.0% |
Q2 2015 | $2,129,000 | +29.4% | 44,883 | -0.0% | 0.00% | 0.0% |
Q1 2015 | $1,645,000 | +18.9% | 44,895 | +28.9% | 0.00% | 0.0% |
Q4 2014 | $1,383,000 | -11.5% | 34,817 | -55.5% | 0.00% | 0.0% |
Q3 2014 | $1,562,000 | +2197.1% | 78,303 | +1466.1% | 0.00% | – |
Q4 2013 | $68,000 | +47.8% | 5,000 | +25.0% | 0.00% | – |
Q3 2013 | $46,000 | – | 4,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |